Nicotine increases survival in human colon cancer cells treated with chemotherapeutic drugs

Toxicology in Vitro

Volumn 27, Issue 8, 2013, Pages 2256-2263

  Dinicola, Simona ^a   Morini, Veronica ^a   Coluccia, Pierpaolo ^a   Proietti, Sara ^a   D'Anselmi, Fabrizio ^a   Pasqualato, Alessia ^a,b   Masiello, Maria Grazia ^a   Palombo, Alessandro ^c   De Toma, Giorgio ^a   Bizzarri, Mariano ^a   Cucina, Alessandra ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF CHIETI   (Italy)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

5 Fluorouracil; AKT; Apoptosis; Camptothecin; ERK; Nicotine

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; ALPHA BUNGAROTOXIN; ANTINEOPLASTIC AGENT; CAMPTOTHECIN; CASPASE 3; CASPASE 7; FLUOROURACIL; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE INHIBITOR; NICOTINE; PROTEIN KINASE B;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER GROWTH; CANCER SURVIVAL; CELL CULTURE; CELL PROLIFERATION; CELL STIMULATION; CELL STRAIN; CELL STRAIN CACO 2; CELL STRAIN HCT 8; CELL VIABILITY; COLORECTAL CANCER; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SMOKING;

5-FLUOROURACIL; AKT; APOPTOSIS; CAMPTOTHECIN; ERK; NICOTINE;

ALPHA7 NICOTINIC ACETYLCHOLINE RECEPTOR; ANTINEOPLASTIC AGENTS; APOPTOSIS; CACO-2 CELLS; CAMPTOTHECIN; CELL LINE, TUMOR; CELL SURVIVAL; COLONIC NEOPLASMS; DRUG INTERACTIONS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FLUOROURACIL; HUMANS; NICOTINE; PROTO-ONCOGENE PROTEINS C-AKT;

EID: 84885918497     PISSN: 08872333     EISSN: 18793177     Source Type: Journal    
DOI: 10.1016/j.tiv.2013.09.020     Document Type: Article

References (35)

1. Balmanno K., Cook S.J. Tumour cell survival signalling by the ERK1/2 pathway. Cell Death Differ. 2009, 16:368-377.
2. Bellacosa A., Kumar C.C., Di Cristofano A., Testa J.R. Activation of AKT kinases in cancer: implications for therapeutic targeting. Adv. Cancer Res. 2005, 94:29-86.
3. Cagnol S., Chambard J.-C. ERK and cell death: mechanisms of ERK-induced cell death - apoptosis, autophagy and senescence. FEBS J. 2010, 277:2-21.
4. Cataldo J.K., Dubey S., Prochaska J.J. Smoking cessation: an integral part of lung cancer treatment. Oncology 2010, 78:289-301.
5. Chang G.C., Hsu S.L., Tsai J.R., Wu W.J., Chen C.Y., Sheu G.T. Extracellular signal-regulated kinase activation and Bcl-2 downregulation mediate apoptosis after gemcitabine treatment partly via a p53-independent pathway. Eur. J. Pharmacol. 2004, 502:169-183.
6. Chumakova O.V., Liopo A.V., Evers B.M., Esenaliev R.O. Effect of 5-fluorouracil, optison and ultrasound on MCF-7 cell viability. Ultrasound Med. Biol. 2006, 32:751-758.
7. Cucina A., Dinicola S., Coluccia P., Proietti S., D'Anselmi F., Pasqualato A., Bizzarri M. Nicotine stimulates proliferation and inhibits apoptosis in colon cancer cell lines through activation of survival pathways. J. Surg. Res. 2012, 178:233-241.
8. D'Amours D., Sallmann F.R., Dixit V.M., Poirier G.G. Gain-of-function of poly(ADP-ribose) polymerase-1 upon cleavage by apoptotic proteases, implications for apoptosis. J. Cell Sci. 2001, 114:3771-3778.
9. Dasgupta P., Kinkade R., Joshi B., DeCook C., Haura E., Chellappan S. Nicotine inhibits apoptosis induced by chemotherapeutic drugs by up-regulating XIAP and survivin. Proc. Natl. Acad. Sci. USA 2006, 103:6332-6337.
10. Dasgupta P., Rizwani W., Pillai S., Kinkade R., Kovacs M., Rastogi S., Banerjee S., Carless M., Kim E., Coppola D., Haura E., Chellappan S. Nicotine induces cell proliferation, invasion and epithelial-mesenchymal transition in a variety of human cancer cell lines. Int. J. Cancer 2009, 124:36-45.
11. Egleton R.D., Brown K.C., Dasgupta P. Nicotinic acetylcholine receptors in cancer: multiple roles in proliferation and inhibition of apoptosis. Trends Pharmacol. Sci. 2008, 29:151-158.
12. Hukkanen J., Jacob P., Benowitz N.L. Metabolism and disposition kinetics of nicotine. Pharmacol. Rev. 2005, 57:79-115.
13. Jemal A., Siegel R., Xu J., Ward E. Cancer statistics. CA Cancer J. Clin. 2010, 60:277-300.
14. Kim M., Yan Y., Kortum R.L., Stoeger S.M., Sgagias M.K., Lee K., Lewis R.E., Cowan K.H. Expression of kinase suppressor of Ras1 enhances cisplatin-induced extracellular signal-regulated kinase activation and cisplatin sensitivity. Cancer Res. 2005, 65:3986-3992.
15. Li T.-K., Houghton P.J., Desai S.D., Daroui P., Liu A.A., Hars E.S., Ruchelman A.L., LaVoie E.J., Liu L.F. Characterization of ARC-111 as a novel topoisomerase I - targeting anticancer drug. Cancer Res. 2003, 63:8400-8407.
16. Li J., Hou N., Faried A., Tsutsumi S., Takeuchi T., Kuwano H. Inhibition of autophagy by 3-MA enhances the effect of 5-FU-induced apoptosis in colon cancer cells. Ann. Surg. Oncol. 2009, 16:761-771.
17. Liang P.S., Chen T.-Y., Giovannucci E. Cigarette smoking and colorectal cancer incidence and mortality: systematic review and meta-analysis. Int. J. Cancer 2009, 124:2406-2415.
18. Lim Y.J., Rhee J.C., Bae Y.M., Chun W.J. Celecoxib attenuates 5-fluorouracil-induced apoptosis in HCT-15 and HT-29 human colon cancer cells. World J. Gastroenterol. 2007, 13:1947-1952.
19. Longley D.B., Harkin D.P., Johnston P.G. 5-Fluorouracil: mechanisms of action and clinical strategies. Nat. Rev. Cancer 2003, 3:330-338.
20. Magrini R., Bhonde M.R., Hanski M.L., Notter M., Scherübl H., Boland C.R., Zeitz M., Hanski C. Cellular effects of CPT-11 on colon carcinoma cells: dependence on p53 and hMLH1 status. Int. J. Cancer 2002, 101:23-31.
21. Makin G., Hickman J.A. Apoptosis and cancer chemotherapy. Cell Tiss. Res. 2000, 301:143-152.
22. Nordman I.C., Iyer S., Joshua A.M., Clarke S.J. Advance in the adjuvant treatment of colorectal cancer. ANZ J. Surg. 2006, 76:373-380.
23. Pommier Y. Topoisomerase I inhibitors: camptothecins and beyond. Nat. Rev. Cancer 2006, 6:789-802.
24. Roy H.K., Olusola B.F., Clemens D.L., Karolski W.J., Ratashak A., Lynch H.T., Smyrk T.C. AKT proto-oncogene overexpression is an early event during sporadic colon carcinogenesis. Carcinogenesis 2002, 23:201-205.
25. Shen T., Le W., Yee A., Kamdar O., Hwang P.H., Upadhyay D. Nicotine induces resistance to chemotherapy in nasal epithelial cancer. Am. J. Rhinol. Allergy 2010, 24:e73-e77.
26. Sheng S., Qiao M., Pardee A.B. Metastasis and AKT activation. J. Cell. Physiol. 2009, 218:451-454.
27. Tsoi K.K., Pau C.Y., Wu W.K., Chan F.K., Griffiths S., Sung J.J. Cigarette smoking and the risk of colorectal cancer: a meta-analysis of prospective cohort studies. Clin. Gastroenterol. Hepatol. 2009, 7:682-688.
28. Vincenzi B., Santini D., Loupakis F., Addeo R., Rojas-Llimpe F.L., Baldi G.G., Di Fabio F., Del Prete S., Pinto C., Falcone A., Tonini G. Cigarettes smoking habit may reduce benefit from cetuximab-based treatment in advanced colorectal cancer patients. Expert Opin. Biol. Ther. 2009, 9:945-949.
29. Wang X., Martindale J.L., Holbrook N.J. Requirement for ERK activation in cisplatin-induced apoptosis. J. Biol. Chem. 2000, 275:39435-39443.
30. Whitacre C.M., Zborowska E., Willson J.K., Berger N.A. Detection of poly(ADP-ribose) polymerase cleavage in response to treatment with topoisomerase I inhibitors: a potential surrogate end point to assess treatment effectiveness. Clin. Cancer Res. 1999, 5:665-672.
31. Wong H.P., Yu L., Lam E.K., Tai E.K., Wu W.K., Cho C.H. Nicotine promotes cell proliferation via alpha7-nicotinic acetylcholine receptor and catecholamine-synthesizing enzymes-mediated pathway in human colon adenocarcinoma HT-29 cells. Toxicol. Appl. Pharmacol. 2007, 221:261-267.
32. Xu J., Huang H., Pan C., Zhang B., Liu X., Zhang L. Nicotine inhibits apoptosis induced by cisplatin in human oral cancer cells. Int. J. OralMaxillofac. Surg. 2007, 36:739-744.
33. Ye Y.N., Liu E.S., Shin V.Y., Wu W.K., Luo J.C., Cho C.H. Nicotine promoted colon cancer growth via epidermal growth factor receptor, c-Src, and 5-lipoxygenase-mediated signal pathway. J. Pharmacol. Exp. Ther. 2004, 308:66-72.
34. Zevin S., Benowitz N.L. Drug interactions with tobacco smoking: an update. Clin. Pharmacokinet. 1999, 36:425-438.
35. Zhao Y., Shen S., Guo J., Chen H., Greenblatt D.Y., Kleeff J., Liao Q., Chen G., Friess H., Leung P.S. Mitogen-activated protein kinases and chemoresistance in pancreatic cancer cells. J. Surg. Res. 2006, 136:325-335.